Welcome to UCL Cancer Institute
The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. If you are thinking about studying with us, applications to our flagship MSc Cancer postgraduate programme is open to application for September 2018 start.
News and features
A large international study led by UCL and UCLH researchers, has found that an MRI scan and targeted prostate biopsies, are significantly better at making a positive prostate cancer diagnosis than standard biopsies.
Published: Mar 19, 2018 5:08:37 PM
Cancer Research UK is planning to invest nearly £9m over the next five years into research at the Cancer Research UK & UCL Cancer Trials Centre. The announcement is part of a £45 million investment into Cancer Research UK’s network of clinical trials units across the UK, one of the charity’s largest investments in clinical research to date.
Published: Feb 15, 2018 4:51:53 PM
A UK wide research network for osteosarcoma, a rare type of bone cancer primarily affecting teenagers and young adults, is to be set up by UCL, led by Professor Adrienne Flanagan, thanks to a generous gift of £1m from The Tom Prince Cancer Trust.
Published: Feb 14, 2018 10:17:09 AM
Smoking just one cigarette a day carries a much higher risk of developing coronary heart disease and stroke than expected – about half the risk of smoking 20 per day – concludes a new study published in the BMJ today. The findings could have consequences for many smokers and health professionals who believe that smoking only a few cigarettes per day bears little or no harm.
Published: Jan 25, 2018 1:03:28 PM
Researchers have discovered a new way of potentially treating mature T cell cancers using immunotherapy. The study, published in Nature Medicine, demonstrates how chimeric antigen receptor (CAR) T cells can be used to selectively target cancerous T cells.
Published: Dec 22, 2017 12:12:43 PM
Dr Carla Martins, MRC Cancer Unit, Cambridge University, presents: Defining and targeting the phenotypic heterogeneity of mutant Kras lung tumours
Starts: Mar 21, 2018 12:00:00 PM
Cancer Research UK’s inaugural Brain Tumour Conference will bring together cancer research experts to discuss and debate some of the most important issues and discoveries in the field.
Starts: May 1, 2018 9:00:00 AM
Support our work
Help us to continue the research that will lead to the breakthroughs in therapies for cancer patients. Support us >
Action for equality and diversity
UCL Cancer Institute is proud to hold an Athena SWAN silver award in recognition of our commitment to advancing equality and diversity.